CoChat

Blood-based biomarkers of microvascular pathology in Alzheimer’s disease

Open access
Ewers, Michael, Mielke, Michelle M., Hampel, Harald · 2010 · Experimental Gerontology
Cited by 122

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

SporadicAlzheimer’s disease (AD) is a genetically complex and chronically progressive neurodegenerative disorder with molecular mechanisms and neuropathologies centering around the amyloidogenic pathway, hyperphosphorylation and aggregation of tau protein, and neurofibrillary degeneration. While cerebrovascular changes have not been traditionally considered to be a central part of AD pathology, a growing body of evidence demonstrates that they may, in fact, be a characteristic feature of the AD brain as well. In particular, microvascular abnormalities within the brain have been associated with pathological AD hallmarks and may precede neurodegeneration. In-vivo assessment of microvascular pathology provides a promising approach to develop useful biological markers for early detection and pathological characterization of AD. This review focuses on established blood-based biological marker candidates of microvascular pathology in AD. These candidates include plasma concentration of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) that are increased in AD. Measures of endothelial vasodilatory function including endotheline (ET-1), adrenomedulline (ADM), and atrial natriuretic peptide (ANP), as well as sphingolipids are also significantly altered in mild AD or during the predementia stage of mild cognitive impairment (MCI), suggesting sensitivity of these biomarkers for early detection and diagnosis. In conclusion, the emerging clinical diagnostic evidence for the value of blood-based microvascular biomarkers in AD is promising, hoewever, still requires validation in phase II and III diagnostic trials. Moreover, it is still unclear whether the described protein dysballances are early or downstream pathological events and how the detected systemic microvascular alterations relate to cerebrovascular and neuronal -pathologies in the AD brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.exger.2009.09.005

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 122

Metadata

Authors
Ewers, M., Mielke, M. M., & Hampel, H.
Venue
Experimental Gerontology
Publisher
Elsevier BV
Published
2010-01
Volume
45
Issue
1
Pages
75-79
ISSN
0531-5565 (ISSN-L)
OpenAlex
W2066450419
Cited by
122
References
11
FWCI
6.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood-based biomarkers of microvascular pathology in Alzheimer’s disease. https://app.cochat.ai/papers/10.1016/j.exger.2009.09.005
The paper
Ewers, M., Mielke, M. M., & Hampel, H. (2010). Blood-based biomarkers of microvascular pathology in Alzheimer’s disease. Experimental Gerontology. https://doi.org/10.1016/j.exger.2009.09.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.